No abstract available
MeSH terms
-
Alzheimer Disease / pathology*
-
Alzheimer Disease / physiopathology
-
Alzheimer Disease / prevention & control
-
Amyloid beta-Peptides / drug effects
-
Amyloid beta-Peptides / metabolism
-
Animals
-
Brain / drug effects*
-
Brain / metabolism
-
Brain / pathology*
-
Disease Models, Animal
-
Dose-Response Relationship, Drug
-
Down-Regulation / drug effects
-
Down-Regulation / physiology
-
Drug Administration Schedule
-
Early Diagnosis
-
Hydroxymethylglutaryl-CoA Reductase Inhibitors / pharmacology*
-
Hydroxymethylglutaryl-CoA Reductase Inhibitors / therapeutic use
-
Hypercholesterolemia / complications
-
Hypercholesterolemia / drug therapy
-
Hypercholesterolemia / metabolism
-
Mice
-
Neurofibrillary Tangles / drug effects
-
Neurofibrillary Tangles / metabolism
-
Neurofibrillary Tangles / pathology
-
Neuroprotective Agents / pharmacology*
-
Neuroprotective Agents / therapeutic use
-
Plaque, Amyloid / drug effects
-
Plaque, Amyloid / metabolism
-
Plaque, Amyloid / pathology
-
Research Design
Substances
-
Amyloid beta-Peptides
-
Hydroxymethylglutaryl-CoA Reductase Inhibitors
-
Neuroprotective Agents